TrinetX: Global Health Research Network and Data Analytics
Accelerating Evidence-Based Research with Real-World Data
Overview of TrinetX and Its Impact on Global Health Research
TrinetX is a leading real-world data (RWD) and analytics platform that connects healthcare organizations, life sciences companies, and researchers to a vast global network of electronic health records (EHRs), claims data, and clinical research insights. The platform enables retrospective and prospective analyses, helping researchers generate real-world evidence (RWE) for epidemiological studies, clinical trials, and health outcomes research.
At Clievi, we leverage TrinetX’s robust data analytics capabilities to support evidence-based decision-making, disease modeling, patient cohort identification, and predictive analytics. Our expertise in handling large-scale healthcare datasets ensures high-quality insights for pharmaceutical companies, contract research organizations (CROs), regulatory bodies, and academic researchers.
Our TrinetX Data Analytics Services
1. Real-World Evidence (RWE) Generation
We utilize TrinetX’s extensive de-identified patient datasets to conduct high-quality, regulatory-compliant real-world studies. Key RWE applications include:
- Comparative Effectiveness Research (CER) – Evaluating treatment efficacy across diverse patient populations.
- Drug Utilization Studies (DUS) – Analyzing prescription patterns, adherence, and safety profiles.
- Longitudinal Patient Journey Mapping – Tracking disease progression, treatment response, and clinical outcomes.
- Epidemiological Insights – Investigating disease prevalence, incidence rates, and comorbidities in real-world settings.
Our TrinetX-powered RWE solutions enable pharmaceutical firms and healthcare providers to make data-driven clinical and commercial decisions.
2. Patient Cohort Identification and Feasibility Analysis
Using TrinetX’s real-time querying tools, we assist researchers in identifying suitable patient cohorts for clinical studies. Our services include:
- Inclusion and Exclusion Criteria Optimization – Ensuring patient eligibility based on demographic, clinical, and laboratory parameters.
- Multi-Site and Global Patient Recruitment – Enhancing recruitment efficiency for multi-center clinical trials.
- Retrospective and Prospective Cohort Analyses – Enabling precise patient stratification for observational and interventional studies.
- Synthetic Control Arms for Clinical Trials – Constructing external control arms using historical patient data to support regulatory submissions.
By leveraging TrinetX’s global network of healthcare institutions, we accelerate study feasibility assessments and enhance trial efficiency.
3. Clinical Trial Optimization and Site Selection
TrinetX provides real-time access to EHR data, helping sponsors and CROs optimize clinical trial design and site selection. Our services include:
- Protocol Feasibility Assessment – Validating study protocols against real-world patient populations.
- Geospatial Site Selection Analytics – Identifying highly active clinical sites with eligible patient populations.
- Trial Enrollment Forecasting – Predicting recruitment timelines based on historical site performance.
- Patient Retention and Dropout Analysis – Mitigating attrition risks to ensure study completion.
With data-driven site selection strategies, we help organizations reduce recruitment timelines and enhance study success rates.
4. Post-Marketing Surveillance and Pharmacovigilance
Post-market safety and efficacy monitoring is critical for regulatory compliance and drug lifecycle management. We use TrinetX RWD analytics to:
- Monitor Drug Safety and Adverse Events – Detecting and analyzing real-world safety signals.
- Real-Time Pharmacovigilance Dashboards – Visualizing safety trends across diverse populations.
- Health Outcomes Monitoring – Assessing long-term treatment effectiveness.
- Risk-Benefit Evaluations – Supporting regulatory decisions through post-market evidence.
Our post-marketing surveillance solutions help biopharmaceutical companies and regulatory authorities ensure drug safety and effectiveness in real-world clinical practice.
5. Health Economics and Outcomes Research (HEOR)
We integrate TrinetX data analytics into health economic evaluations to demonstrate the cost-effectiveness and real-world impact of healthcare interventions. Our key services include:
- Cost-Effectiveness and Budget Impact Analysis – Evaluating treatment value and economic sustainability.
- Healthcare Resource Utilization (HRU) Studies – Assessing the economic burden of diseases and interventions.
- Quality-Adjusted Life Years (QALYs) and Disability-Adjusted Life Years (DALYs) Calculation – Measuring treatment impact on patient quality of life.
- Payer and Reimbursement Strategy Support – Generating real-world cost and outcome data for market access.
Our HEOR-driven insights support healthcare decision-makers, payers, and policymakers in optimizing healthcare spending and reimbursement models.
Why Choose Clievi for TrinetX-Based Data Analytics?
- Expertise in Real-World Data Analytics – Proficient in handling TrinetX’s vast healthcare datasets and analytics tools.
- Regulatory-Compliant RWE Solutions – Supporting submissions to FDA, EMA, NICE, and other regulatory bodies.
- Advanced AI-Driven Predictive Modeling – Utilizing machine learning and AI algorithms for disease forecasting.
- Comprehensive End-to-End Research Support – Covering data extraction, analysis, visualization, and reporting.
- Proven Track Record in HEOR and Epidemiology Research – Delivering high-impact insights for public health, pharmaceuticals, and clinical trials.
Deliverables of Our TrinetX Services
- Customized Real-World Evidence (RWE) Reports – Providing in-depth epidemiological, clinical, and economic analyses.
- Patient Cohort Analytics Dashboards – Enabling real-time patient recruitment and feasibility analysis.
- Clinical Trial Site Selection Reports – Optimizing trial planning and site performance benchmarking.
- Post-Marketing Surveillance and Drug Safety Reports – Monitoring long-term treatment outcomes and adverse events.
- Health Economic Models and Budget Impact Analysis – Supporting payer negotiations and market access strategies.
Industries We Serve
- Pharmaceutical and Biotechnology Companies – Supporting drug development, regulatory approval, and market access.
- Contract Research Organizations (CROs) – Enhancing clinical trial design and patient recruitment strategies.
- Healthcare Payers and Insurance Companies – Providing cost-effectiveness and healthcare utilization insights.
- Government and Public Health Agencies – Assisting in disease surveillance and policy-making.
- Academic Research Institutions – Enabling data-driven epidemiological and health outcomes research.
Contact Us
Maximize the power of TrinetX’s real-world data analytics to drive evidence-based healthcare decisions. Connect with Clievi today.
Email:
Website: www.clievi.com